NASDAQ:NXL Nexalin Technology (NXL) Stock Price, News & Analysis → Moonshot Coins for the Current Crypto Run (From Crypto 101 Media) (Ad) Free NXL Stock Alerts $0.90 -0.48 (-34.80%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.80▼$1.4550-Day Range$0.62▼$2.4852-Week Range$0.25▼$3.40Volume3.93 million shsAverage Volume490,179 shsMarket Capitalization$6.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Nexalin Technology alerts: Email Address Nexalin Technology MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.03% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 8 Articles This WeekInsider TradingAcquiring Shares$1,920 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.82 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Nexalin Technology.Read more about Nexalin Technology's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.03% of the float of Nexalin Technology has been sold short.Short Interest Ratio / Days to CoverNexalin Technology has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nexalin Technology has recently decreased by 16.87%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNexalin Technology does not currently pay a dividend.Dividend GrowthNexalin Technology does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NXL. Previous Next 1.9 News and Social Media Coverage News SentimentNexalin Technology has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Nexalin Technology this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for NXL on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Nexalin Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nexalin Technology insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,920.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.69% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.65% of the stock of Nexalin Technology is held by institutions.Read more about Nexalin Technology's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nexalin Technology is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nexalin Technology is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNexalin Technology has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Nexalin Technology's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIThere’s only one solution to the impending energy catastrophe… Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! About Nexalin Technology Stock (NASDAQ:NXL)Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Read More NXL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXL Stock News HeadlinesJune 14 at 8:21 AM | investorplace.comWhy Is Nexalin Technology (NXL) Stock Down 29% Today?June 14 at 2:20 AM | americanbankingnews.comNexalin Technology (NXL) & Its Peers Head to Head AnalysisJune 14 at 1:20 AM | americanbankingnews.comNexalin Technology (NASDAQ:NXL) & NeurAxis (NASDAQ:NRXS) Financial ReviewJune 13 at 3:00 PM | globenewswire.comNexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)June 11, 2024 | americanbankingnews.comContrasting Nexalin Technology (NXL) & Its RivalsJune 8, 2024 | americanbankingnews.comReviewing Nexalin Technology (NXL) & The CompetitionJune 4, 2024 | globenewswire.comNexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thJune 3, 2024 | globenewswire.comFDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceMay 22, 2024 | globenewswire.comNexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research EffortsMay 13, 2024 | finance.yahoo.comNexalin Technology First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.10 loss in 1Q 2023)May 13, 2024 | investorplace.comNXL Stock Earnings: Nexalin Technology Reported Results for Q1 2024May 9, 2024 | finance.yahoo.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23April 25, 2024 | finanznachrichten.deNexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsApril 25, 2024 | globenewswire.comNexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsApril 12, 2024 | investing.comNexalin Technology advances in mental health treatmentApril 10, 2024 | globenewswire.comNexalin Technology CEO Provides Letter to ShareholdersApril 6, 2024 | stockhouse.comNexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity(TM), a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceApril 4, 2024 | globenewswire.comNexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceApril 2, 2024 | proactiveinvestors.comNexalin Technology's neurostimulation device shows promise in easing mTBI symptoms in veteransApril 2, 2024 | globenewswire.comNexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory BoardMarch 30, 2024 | finance.yahoo.comNexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022)March 28, 2024 | globenewswire.comNexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San DiegoMarch 14, 2024 | finance.yahoo.comNexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s TechnologyMarch 14, 2024 | globenewswire.comNexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's TechnologyMarch 13, 2024 | globenewswire.comNexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”See More Headlines Receive NXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today6/15/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NXL CUSIPN/A CIK1527352 Webwww.nexalin.com Phone832-260-0222FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,650,000.00 Net Margins-3,088.12% Pretax Margin-3,093.12% Return on Equity-154.84% Return on Assets-122.94% Debt Debt-to-Equity RatioN/A Current Ratio5.06 Quick Ratio4.75 Sales & Book Value Annual Sales$158,859.00 Price / Sales42.10 Cash FlowN/A Price / Cash FlowN/A Book Value$0.43 per share Price / Book2.09Miscellaneous Outstanding Shares7,437,000Free Float5,378,000Market Cap$6.69 million OptionableNot Optionable Beta5.13 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Mark White (Age 62)President, CEO, CFO & Director Comp: $442.5kDr. David Owens M.D. (Age 63)Chief Medical Officer & Director Comp: $42.8kMr. Michael Nketiah (Age 48)Senior Vice-President of Quality, Regulatory & Clinical Affairs Comp: $280kMs. Marilyn Elson (Age 71)Controller Comp: $382.72kMr. John Patrick ClaudeCo-Founder and Director of Engineering & DevelopmentKey CompetitorsQT ImagingNASDAQ:QTIStar EquityNASDAQ:STRRGigCapital5NYSE:GIABioSig TechnologiesNASDAQ:BSGMNuwellisNASDAQ:NUWEView All CompetitorsInsidersDavid OwensBought 3,000 shares on 6/10/2024Total: $1,920.00 ($0.64/share)View All Insider Transactions NXL Stock Analysis - Frequently Asked Questions How have NXL shares performed in 2024? Nexalin Technology's stock was trading at $0.4048 on January 1st, 2024. Since then, NXL stock has increased by 122.1% and is now trading at $0.8992. View the best growth stocks for 2024 here. Are investors shorting Nexalin Technology? Nexalin Technology saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 60,600 shares, a drop of 16.9% from the May 15th total of 72,900 shares. Based on an average daily volume of 544,300 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.0% of the company's shares are short sold. View Nexalin Technology's Short Interest. When is Nexalin Technology's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our NXL earnings forecast. How were Nexalin Technology's earnings last quarter? Nexalin Technology, Inc. (NASDAQ:NXL) issued its quarterly earnings data on Wednesday, March, 27th. The company reported ($0.10) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter. Nexalin Technology had a negative trailing twelve-month return on equity of 154.84% and a negative net margin of 3,088.12%. When did Nexalin Technology IPO? Nexalin Technology (NXL) raised $10 million in an initial public offering (IPO) on Friday, September 16th 2022. The company issued 2,315,000 shares at $4.15 per share. How do I buy shares of Nexalin Technology? Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NXL) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
